penses ative expens ost (Loss) ders of the C oods Sold/Ne fit/Net Sale ost/ Net Sale ase be inform urs sincerely, . Sineemas S ef Executive horized Direc ults and fina HB : Million es Company t Sale ed
interest from 28.49% to 20.56% as a consequence of newly issued ordinary shares of Pimai Salt Company Limited. * Note Please find further information in the consolidated financial statements. 2 Summary of
recorded from the change in the Company’s ownership interest from 28.49% to 20.56% as a consequence of newly issued ordinary shares of Pimai Salt Company Limited. * Note Please find further information in
+ $ % !)& $% $' ก8#% !)& * .$ $ ' ))!$% )#9 1 "ก!#1 $% $ก ?&% )%!## #!2A 2 )& ) "! 31 D! 2555 2 ก ก ! " 3 1 " ก ? ก1329=ก:93ก.FB00-41 1.I>3กE=/I1ก9- Q0 EFRL0-41 I4B/กHB 10.0000 =00-4 ก0..FB00-4
) (800) (400) - 400 800 Beginning Operating activities Interest and Tax Investing activities Financing activities Dividend payment Different in FX rate Ending ( T HB m n )
หมุนเวียนการลงทนุของกองทุนรวม (Portfolio Turnover Ratio : PTR) =
of Solvay Biochemicals (Taixing) Limited (“SBT”) in 2017. 3. In 2018, the Company and its subsidiaries recorded loss on dilution on investment in Pimai Salt Company Limited amounting to 32 MB from the
Financing Activities Adjustment and different in FX rate Ending 31 Dec 2018 (T HB m n )
Activities Financing Activities Adjustment and different in FX rate Ending 31 Mar 2019 (T HB m n )
and 2019, the Company recorded tax expenses of THB 35.3 million and 5.7 million, a decrease of HB 5.7 million, or 83.9% which was mainly due to tax benefits received from the Board of Investment of